Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition With Pembrolizumab Outcomes in Advanced Melanoma: Pooled Analysis of 3 Clinical Trials

IMPORTANCE: The optimal sequencing of immune checkpoint inhibitors and targeted therapy for BRAF V600E/K-mutant melanoma is not well established. OBJECTIVE: To assess the association of BRAF wild-type (WT) or BRAF V600E/K-mutant status and BRAF inhibitor (BRAFi) with or without MEK inhibitor (MEKi)...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Oncol
Main Authors: Puzanov, Igor, Ribas, Antoni, Robert, Caroline, Schachter, Jacob, Nyakas, Marta, Daud, Adil, Arance, Ana, Carlino, Matteo S., O’Day, Steven J., Long, Georgina V., Margolin, Kim A., Dummer, Reinhard, Schadendorf, Dirk, Lutzky, Jose, Ascierto, Paolo A., Tarhini, Ahmad, Lin, Jianxin, Mogg, Robin, Homet Moreno, Blanca, Ibrahim, Nageatte, Hamid, Omid
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2020
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7366279/
https://ncbi.nlm.nih.gov/pubmed/32672795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.2288
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker